SGLT2 Inhibitors Curb AF Post-Ablation Recurrences in T2D :

Retrospective, observational data from more than 13,000 US patients with type 2 diabetes and atrial fibrillation suggest that SGLT2 inhibitor treatment may cut AF recurrences post-ablation.

Related Keywords

Massachusetts , United States , Burlington , James Januzzi Jr , Division Of Cardiovascular Medicine , Trinetx Analytics Network , Beth Israel Lahey Health , Cardiovascular Medicine , Lahey Hospital , Medical Center , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Atrial Fibrillation , F Atrial Fibrillation , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Tablation , Healthcare Technology , Ealth Care Technology , Electronic Medical Record Emr , Electronic Medical Record , Omputerized Medical Reco ,